國立虎尾科技大學 |

Drugs During Pregnancy = Methodological Aspects /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Drugs During Pregnancy/ by Bengt Källén.
Reminder of title:	Methodological Aspects /
Author:	Källén, Bengt.
Description:	XI, 111 p. 26 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Obstetrics. -
Online resource:	https://doi.org/10.1007/978-3-319-40697-8
ISBN:	9783319406978

Drugs During Pregnancy = Methodological Aspects /
Källén, Bengt.

Drugs During PregnancyMethodological Aspects /[electronic resource] :by Bengt Källén. - 1st ed. 2016. - XI, 111 p. 26 illus. in color.online resource.

Introduction -- The alert clinician -- Animal experiments and adverse drug reaction reports -- Some epidemiological principles -- Pregnancy outcomes with the exception of congenital malformations -- Congenital malformations -- Identification of maternal use of drugs -- The problem of confounding -- Statistics -- Lumping or splitting? Paternal use of drugs -- Timing of drug use and effects on the embryo or fetus -- Repeated studies and meta-analysis -- Pharmacovigilance -- Information on the risk with drug use during pregnancy -- Concluding remarks.

This book addresses methodological aspects of epidemiological studies on maternal drug use in pregnancy. Discussing the existing sources of error and how they can produce incorrect conclusions, it examines various epidemiological techniques and assesses their strengths and weaknesses. These refer both to the identification of outcomes (with special emphasis on congenital malformations) and to the types of exposure (drug use). Further, the book discusses the problem of confounding and how to handle it, and provides a simple introduction to statistics. Special situations, e.g. different types of parental exposure, are examined. Lastly, the book discusses pharmacovigilance and the information problem, concluding with a short list of aspects to consider when one wants to evaluate a published paper in the field. Though the book is primarily intended for pharmacologists, gynecologists and obstetricians, it will benefit all doctors working in perinatal care.

ISBN: 9783319406978

Standard No.: 10.1007/978-3-319-40697-8doiSubjects--Topical Terms:

674110
Obstetrics.

LC Class. No.: RG499.2-991

Dewey Class. No.: 618.2

Drugs During Pregnancy = Methodological Aspects /
LDR:02854nam a22004095i 4500 001 978898
003 DE-He213
005 20200701012943.0
007 cr nn 008mamaa
008 201211s2016 gw | s |||| 0|eng d
020 $a 9783319406978 $9 978-3-319-40697-8
024 7 $a 10.1007/978-3-319-40697-8 $2 doi
035 $a 978-3-319-40697-8
050 4 $a RG499.2-991
050 4 $a RG600-650
072 7 $a MJT $2 bicssc
072 7 $a MED033000 $2 bisacsh
072 7 $a MKC $2 thema
082 0 4 $a 618.2 $2 23
100 1 $a Källén, Bengt. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1272156
245 1 0 $a Drugs During Pregnancy $h [electronic resource] : $b Methodological Aspects / $c by Bengt Källén.
250 $a 1st ed. 2016.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a XI, 111 p. 26 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Introduction -- The alert clinician -- Animal experiments and adverse drug reaction reports -- Some epidemiological principles -- Pregnancy outcomes with the exception of congenital malformations -- Congenital malformations -- Identification of maternal use of drugs -- The problem of confounding -- Statistics -- Lumping or splitting? Paternal use of drugs -- Timing of drug use and effects on the embryo or fetus -- Repeated studies and meta-analysis -- Pharmacovigilance -- Information on the risk with drug use during pregnancy -- Concluding remarks.
520 $a This book addresses methodological aspects of epidemiological studies on maternal drug use in pregnancy. Discussing the existing sources of error and how they can produce incorrect conclusions, it examines various epidemiological techniques and assesses their strengths and weaknesses. These refer both to the identification of outcomes (with special emphasis on congenital malformations) and to the types of exposure (drug use). Further, the book discusses the problem of confounding and how to handle it, and provides a simple introduction to statistics. Special situations, e.g. different types of parental exposure, are examined. Lastly, the book discusses pharmacovigilance and the information problem, concluding with a short list of aspects to consider when one wants to evaluate a published paper in the field. Though the book is primarily intended for pharmacologists, gynecologists and obstetricians, it will benefit all doctors working in perinatal care.
650 0 $a Obstetrics. $3 674110
650 0 $a Pharmacotherapy. $3 973587
650 1 4 $a Obstetrics/Perinatology/Midwifery. $3 1200342
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319406961
776 0 8 $i Printed edition: $z 9783319406985
776 0 8 $i Printed edition: $z 9783319821580
856 4 0 $u https://doi.org/10.1007/978-3-319-40697-8
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)